SCHEMBL31240460

SCHEMBL31240460

Nc1n[nH]c2ccc(-c3ccnc(Nc4ccccc4O)c3)cc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 11/20 0.52
▸ MAPK10 P53779 5/20 0.51
▸ PDPK1 O15530 1/20 0.45
▸ TYK2 P29597 2/20 0.44
▸ JAK3 P52333 2/20 0.44
▸ JAK1 P23458 2/20 0.44
▸ LRRK2 Q5S007 1/20 0.44
▸ CDC7 O00311 1/20 0.41
▸ PLK4 O00444 1/20 0.41
▸ DAPK3 O43293 1/20 0.41
▸ DYRK3 O43781 1/20 0.41
▸ ROCK2 O75116 1/20 0.41
▸ PRKD3 O94806 1/20 0.41
▸ MAP4K4 O95819 1/20 0.41
▸ CDK1 P06493 1/20 0.41
▸ ROS1 P08922 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ MARK3 P27448 1/20 0.41
▸ KDR P35968 1/20 0.41
▸ CLK2 P49760 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240400 0.83 JAK2 (0.57) JAK2MAPK10PDPK1TYK2JAK3
SCHEMBL31240265 0.83 JAK2 (0.61) JAK2MAPK10PDPK1TYK2JAK3
SCHEMBL31240573 0.82 JAK2 (0.57) JAK2MAPK10PDPK1TYK2JAK3
SCHEMBL31240348 0.81 JAK2 (0.53) JAK2MAPK10PDPK1TYK2JAK3
SCHEMBL31240511 0.81 TNIK (0.52) JAK2MAPK10
SCHEMBL31240424 0.81 JAK2 (0.50) JAK2PDPK1TYK2JAK3LRRK2
SCHEMBL31240469 0.79 JAK2 (0.48) JAK2PDPK1TYK2JAK3LRRK2
SCHEMBL31240615 0.79 JAK2 (0.48) JAK2PDPK1TYK2JAK3LRRK2
SCHEMBL31240314 0.78 JAK2 (0.68) JAK2MAPK10PDPK1TYK2JAK3
SCHEMBL31240438 0.78 JAK2 (0.52) JAK2MAPK10PDPK1TYK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback